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 Accumulating evidence has indicated the presence of 
HTLV-I quasispecies in infected individuals. To elucidate 
their biological consequences, we amplified the whole Tax 
open reading frame (ORF) of HTLV-I proviruses by nested PCR 
from six infected individuals, including three HAM/TSP 
patients, and a cloned HTLV-I DNA, pMT2, and the products 
were introduced into an expression vector. The potential for 
transcriptional transactivation of protein products of inde-
pendent 20-39 tax clones derived from each sample was 
evaluated by transfecting into pA18G-BHK-21 cells containing 
the HTLV-I LTR-driven lacZ gene. While all of 30 clones derived 
from pMT2 gave positive results, significant proportions, ranged 
between 16.0 and 35.0%, of the tax clones from the infected indiv 
iduals were functionally defective. The functional loss of these 
tax clones was confirmed by chloramphenicol acetyltransferase 
(CAT) assay in cells cotransfected with an HTLV-I LTR-CAT 
reporter. DNA sequence analysis revealed that the defective 
clones contained at least one nonsynonymous nucleotide 
substitutions from the consensus sequences of the individual. 
These findings strongly suggested that the accumulation of 
HTLV-I proviruses with defective tax was a common feature 
among infected individuals. Since the Tax protein is indis-
pensable for viral replication, these defective viruses were 
likely to be generated in individuals after the event of 
infection. It is conceivable that the quasispecies plays a key 
role in the latency of HTLV-I infection and possibly in 
HTLV-I-related pathogenesis.
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Introduction 
 Human T-cell lymphotropic virus type I (HTLV-I) is 
a causative agent of adult T-cell leukemia (ATL)'"2', 
HTLV-I-associated myelopathy/tropical spastic paraparesis 
(HAM/TSP) 3,4', and other chronic inflammatory disorders 
of various organs"". HTLV-I transmits horizontally via 
sexual contact and blood transfusion as well as vertically 
through breastfeeding". The virus persists as a proviral 
DNA in T cells of infected individuals and after a long 
latency a minor population of carriers develops HTLV-I-
associated diseases',". The molecular mechanisms involved 
in exerting the pathogenicity of the virus are not yet fully 
understood. 
 HTLV-I is a very old virus which has been conserved 
among human populations in some geographical regions 
for a long time". In contrast to other RNA viruses 
including human immunodeficiency virus (HIV), 
HTLV-I is thought to be structurally stable because 
little divergence in the nucleotide sequence has been 
identified among HTLV-I isolates derived from different 
geographical regions throughout the worlds'. The nucleotide 
diversity of HTLV-I among isolates is estimated to be 
about 20 times smaller than that of other RNA viruses 
such as the influenza A virus and HIT". However, 
recent studies have shown some intrastrain variability 
in the pX region of the HTLV-I proviral genome, 
indicating the presence of the HTLV-I quasispecies in 
an infected individual' ,12,13'. The pX region encodes a 
transcriptional transactivator, Tax, which activates its 
own viral promoter in the LTR sequence and is thought 
to be indispensable for viral replication","). In addition, 
Tax has the potential to upregulate the expression of 
various cellular genes involving cell proliferation, 
including interleukin-2 (IL2)16,"', IL2 receptor- a 18.'9,2°' 
IL621>, GM-CSF22,231, and c-fos24,25'. Moreover, Tax is known 
to be a dominant target antigenic molecule of cytotoxic 
T lymphocytes (CTL) against HTLV-I in ViVo 21,21'. The 
Tax protein is therefore considered to be a key molecule 
for viral replication, persistency, and the pathogenicity
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of HTLV-I. 
 In the present study, in order to elucidate the biological 
consequences of the HTLV-I quasispecies in infected in 
dividuals, we evaluated the potential for transactivation 
on HTLV-I LTR of the Tax protein encoded by random 
plasmid clones of the Tax open reading frame (ORF) derived 
from HTLV-I proviral DNA of six infected individuals. 
The results indicate that proviruses with functionally 
defective tax genes commonly accumulate in vivo.
MATERIALS AND METHODS 
DNA preparations. 
 The experimental protocol was approved by the Ethics 
Review Committee for Human Experimentation at our 
institution and an informed consent was obtained from 
all subjects. Heparinized peripheral mononuclear cells 
(PBMC) and/or bronchoalveolar lavage cells (BALC) 
were obtained from three HAM/TSP patients and HTLV-I 
carriers. The PBMCs were isolated by Ficoll-Conray 
gradient centrifugation (Daiichi Pharmacecutica, Tokyo, 
Japan), as described"'. Approximately 10' cells were 
lysed in 0.5 ml of lysing buffer (150 mM NaCI, 10 mM 
Tris-HCI [pH8], 10 mM EDTA, 0.5% SDS) and treated 
with proteinase K (100,u g/ml) for 2 h at 50 °C. After 
phenol/chroloform extraction and ethanol precipitation, 
high molecular weight DNA was resuspended in 10 mM 
Tris (pH8), 1 mM EDTA.
Plasmids and cells 
 The expression vector pCG has been described and 
characterized elsewhere". The pCHL4 contained the 
chloramphenicol acetyltransferase (CAT) gene driven 
by a Smal-BglI 1,630 by fragment of HTLV-I LTR30' 
We used the pA18G-BHK-21 cell line (a kind gift from 
Dr. Astier-Gin), a Syrian hamster kidney cell line stably 
transfected with a plasmid vector containing the lacZ 
gene under the control of HTLV-I LTR promoter, whose 
expression was inducible by the Tax protein"). Both 
the cell lines used (pA18-BHK-21 and A293T) were 
maintained in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS).
Amplification and cloning of HTLV-I tax DNA. 
 The whole Tax-ORF of the HTLV-I provirus was am 
plified by nested PCR from 0.5 a g of DNA in a 50 a 1 
cocktail containing 10 mM Tris-HC1 (pH7.5), 50 mM 
KCl, 1.5 MM MgCl2, 0-01% gelatin, 0.25 mM dNTPs, 
1 u M each of primers, and 2.6 units of High - Fidelity
Taq Polymerase (Boehringer Mannheim). The primers 
used were : Tax 11 (5'-GATAGCAAACCGTCAAGCACAG-
3'; positions 7158 to 7179) and Tax6 (5'-TCCTGAACT 
GTCTCCACGCTTT-3'; positions 8650 to 8629) for the 
first amplification, and Tax 15-XB (5'-TACTCTAGAAC 
CATGGCCCACTTCCCAGG-3 ; positions 7324 to 7337) 
and Tax30-Bam (5'-CTGAGGATCAGAGCCTTAGTCT-3'; 
positions 8409 to 8397) for the second amplification. 
Xbal and BamHI restriction sites (underlined) were in-
cluded in Tax 15-XB and Tax30-Barn primers, respec-
tively, to allow subsequent subcloning into pCG. PCR 
was performed in a Thermal Cycler (Biometra) for 30 
cycles: denaturation at 94 °C for 30 sec (2 min on the 
first cycle), annealing at 60 °C for 30 sec, and extension 
at 72 °C for 70 sec (7 min on the last cycle). For the 
nested PCR, 1/10 volume of the first-step PCR product 
purified by Superec II column (Takara Co. Tokyo) was 
further amplified for 27 cycles using the inner primer 
pair. The thermal cycle program was almost the same 
as that used for the first PCR except the annealing temp 
erature was 58 °C for the first 6 cycles and 63 °C for 
the following 21 cycles. The nested PCR product was 
purified on a 1.0% agarose gel (Seakem GTG), di-
gested with Xbal and BamHI, and ligated into the ex-
pression plasmid pCG. After transformation of E. Coli 
(DI-15a), the recombinant clones were randomly picked 
up and the plasmid DNA were miniprepared by the 
NaOH/SDS method.
Transfection. 
 Transient transfection was performed by the lipofection 
method"). Plasmid DNA mixed with 5 p 1 of Lipofectamine 
(GIBCO/BRL) was added to subconfluent cells cultured 
in 5 ml of serum-free DMEM in a 10 cm-diameter dish. 
After incubation for 8 h at 37 °C, 5 ml of DMEM con-
taining 20% FBS was added, and at 24 h, the medium 
was replaced with DMEM containing 10% FBS. The 
cells were used for the following assays 48 h after 
transfection.
Colorimetric assay. 
 The pA18G-BHK-21 cells transfected with pCG-tax 
(0.2,u g) were fixed with 25 % glutaraldehyde and washed 
three times with PBS. The cells were then mixed with 
0.1% X-gal solution and incubated overnight at 37 °C. 
When stained cells were observed in 10 view-fields 
under an inverse microscope (magnification: 100x), 
the sample scored positive for transactivation via 
HTLV-I LTR. Reproducibility of the negative result 
was confirmed by repetitive experiments.
Chrolamphenicol acetyltransferase (CA T) assay. 
 A293T cells co-transfected with pCG-tax (0.2,u g) and 
pCHL4 (1 u g) were harvested and lysed 48 h after 
transfection. Cell extracts (50 p 1) containing 10 u g of 
cellular proteins were mixed with 55 u 1 of 1 M Tris-
HCl (pH7.8), 5p 1 of ['"C]-chloramphenicol (0.05 Ci/ml), 
and 20,a 1 of acetyl coenzyme A. After incubation for 4 h 
at 37 ', chloramphenicol and its acetylated derivatives 
were analyzed by silica-gel thin-layer chromatography 
and autoradiography. The radioactivity of the spots 
was quantified using an image analyzer (BAS 2000; 
Fuji Film, Tokyo, Japan). Efficiency of each transfection 
was monitored by co-transfecting pRSV-lacZ.
DNA sequencing. 
 The whole Tax ORF (1,059 bp) in the plasmid DNA was 
sequenced by the dideoxy chain termination method 
(Thermo Sequenase core sequencing kit, Amersham ) 
using the two kinds of 5' Texas Red-labeled primers 
corresponding to the flanking vector sequences (HSV-tk 
sequence; 5'-GCCCAGCGCCTTGTAGAA-3', and rabbit-
13 -globin sequence; 5'-TAGCGAAAAAGAAAGAAC-3'), 
and analyzed on an automated sequencer (SQ5500 ; 
Hitachi Co, Tokyo, Japan). A sequence comparison was 
carried out using the DDBJ database (J02029).
RESULTS 
HTL V-I proviruses with the functionally defective tax 
gene in infected individuals. 
 We analyzed six HTLV-I-infected individuals including 
three patients with HAM/TSP (I.T., N.O., and D.K.) and 
three healthy carriers (N.M., N.Y., and D.E.). In consistency 
with previous findings'"", the HAM/TSP patients had 
relatively higher serum antibody titers and viral loads 
(data not shown). The whole Tax ORF was amplified 
from genomic DNA samples of the infected individuals 
as well as plasmid DNA containing a cloned HTLV-I, 
pMT235'. The amplified products were inserted into an 
expression plasmid and random 20-39 tax clones were 
obtained from each product. In order to define the biological 
consequence of in vivo HTLV-I quasispecies, the function 
of each of the tax clones was evaluated by transfection 
and a successive colorimetric assay in pA 18G-BHK-21 
cells with the lacZ gene under the control of the HTLV-I 
LTR promoter. Transfection of the wild-type tax successfully 
induced lacZ expression, while the expression plasmid 
without tax insert did not gave any stained cell (Fig. 1). 
When stained cells were observed in 10 view-fields under 
an inverse microscope, the sample scored positive for 
transactivation via HTLV-I LTR. As shown in Table 1,
Fig. 1 Transcriptional transactivation of HTLV-I LTR by Tax. The function of each of the tax 
clones was evaluated by transfection and a successive colorimetric assay in pA 18G-BHK-21 cells 
with the lacZ gene under the control of the HTLV-I LTR promoter. While the expression plasmid 
without tax insert (A) gave no stained cell, transfection of the wild-type tax (B) successfully in-
duced lacZ expression,
Table 1. Proportion of nonfunctional tax clones in HAM/TSP patients and healthy carriers 
                                No. of No. of clones No. of clones Percentage ofDisease Subjects total clones competent for defective for defective clones                                        transactivation transactivation (%) 
              pMT2 30 30 0 0.0
                 I.T. 39 31 8 20.5
   HAM/TSP N.O. 25 21 4 16.0 
                 D.A. 25 21 4 16.0
                 average 17.5
                 N.M. 38 31 7 18.4
 Healthy Carriers N.Y. 20 13 7 35.0 
                  D.H. 25 17 7 32.0
                  average 29.4
all of 30 clones derived from pMT2 gave positive results. 
On the other hand, significant proportions, ranged between 
16 and 35%, of the tax clones from the infected individuals 
were functionally defective. Frequencies of the defective 
tax among three healthy carriers, 18.4, 35.0, and 32.0% 
(average: 29.4%), were higher than those among the 
HAM/TSP patients, 20.5, 16.0, and 16.0% (average: 
17.5%), although the differences between the two were 
statistically insignificant. All the negative results were 
reproducible in repetitive colorimetric assays and were 
further confirmed by CAT assay in A293T cells
                                                  9-gal assay %conversion relative CAT activity 
pCG-BL (-) 8.3 1.0 
pCG-Wt (+) 97.9 11.8 
  2P10 (-) 8.9 1.1 
                                          (-) 3.1 0.4  2B16 `~ 
  3P07 (-) 7.7 0.9 
  3B07 (-) 8.2 1.0 
 3B21 a (+) 93.1 11.2 
  3P19 (-) 7.2 0.9 
  2P14 (+) 98.5 11.9 
 2805 (+) 98.4 11.9 
  2P08 (+) 98.0 11.8 
  3P05 - (+) 98.3 11.9
Fig. 2 Loss of transactivation for the HTLV-I LTR-CAT promoter 
in Tax proteins encoded by in vivo-derived mutants. One 
microgram of the reporter plasmid, pCHL4, was transfected 
together with 0.2p g of the indicated tax clone into A293T 
cells, and CAT activity in the cell extract was analyzed. The 
vectors without tax insert, pCG-BL, and with wild-type tax, 
pCG-Wt, were used as negative and positive controls, respec-
tively. All or nothing results of the colorimetric assay in 
pA 18G-BHK-21 cells are indicated as (+) or (- ). The rela-
tive CAT activity was determined as a ratio of the % conver-
sion between each tax clone and pCG-BL.
cotransfected with a reporter plasmid, pCHL4. Only a 
representative CAT assay is shown in Fig. 2. The clones 
(2P10, 2B16, 3P07, 3B07, and 3P19) defective in the 
colorimetric assay exhibited significant CAT activity, 
but its level (% conversion: 3.1-8.9%) was equivalent 
to that in the cells transfected with the vector without 
tax insert (8.3%). In contrast, functionally competent 
clones (3B21, 2P 14, 2B05, 2P08, and 3P05) were capable 
of converting more than 93.1 % of chrolamphenicol into 
its acetylated forms. Additional CAT assays for the 
remaining tax clones reproduced exclusively the results in 
the colorimetric assay. Expression levels of g -galactosidase 
encoded by the co-transfected pRSV-lacZ were roughly 
equivalent among each transfection (data not shown), 
excluding the possibility that low transfection efficiency 
affected the results of the reporter assay.
Functional loss of in vivo-derived tax clones as a conse-
quence of nonsynonymous nucleotide substitution. 
 To analyze the sequence variation leading to functional 
loss of the tax gene of HTLV-I proviruses in infected 
individuals, 39 tax clones derived from PBMC and
Table 2. Correlation between functional loss and nonsynonymous 
nucleotide stubstitution in tax clones from an HAM/TSP patient 
                                   No. of clones No. of clones
  Transactivation No. of with without                     t
otal clones nonsynonymous nonsynonymous 
                              substitution substitution
    (+) 31 12 19 
    (-) 8 8 0
BALC of a HAM patient (I.T.) were subjected to the 
sequence analysis. Sequence comparison found two 
consensus sequences (Fig. 3) . One (consensus A) was 
identical to the reference, ATKI?6), while the other 
(consensus B) was different at three nucleotide positions 
from ATKI. Among the 39 clones analyzed, 5 and 9 
exactly shared the sequence with consensus A and B, 
respectively, but the remaining 25 contained one to 
four nucleotide substitutions. The distribution of the 41 
substitutions identified in these 25 clones was random and 
encompassed the whole region of the tax gene. About 
three quarters of the substitutions (31/41) resulted in 
amino acid changes (nonsynonymous substitution), 
and a half of the clones (20/39) had one or more 
nonsynonymous substitutions. 
 All the defective tax clones contained one or more n 
onsynonymous nucleotide substitutions (Table 2). Among 
the 20 clones with nonsynonymous nucleotide substitutions,
8 (40%) were functionally defective. As shown in Fig. 4, 
amino acid substitutions possibly causing the functional 
loss of the Tax protein are random and distributed throughout 
the Tax sequence. In one clones (2P01), nonsynonymous 
nucleotide substitution resulted in a termination codon 
at near the amino-terminal portion of the Tax. A single 
amino acid substitution found in a clone (G 14R in 2P 10) 
is likely to be solely responsible for the functional 
loss. The G 14R substitution was also found in the 
other two defective clones (2P1 1 and 21301). Although 
the localization was random, leucine-to-proline (L / P ) 
and serine-to-proline (S/P) substitutions were frequent. 
Interestingly, all the nonsynonymous nucleotide substi-
tutions (T-C conversion) resulting in the proline residue 
were always duplicated in the defective tax clones 
(2P11, 2B08, 2B16, and 2B17). In contrast, each of 
such substitutions found in three functionally competent 
clones was at only a single position (data not shown).
                                                                                                  COLOR. 
position 7324 8382 FREQ ASSAY 
ATKI TG-G--T-------ATCTTA-T-TG--G--C---TTTA-AGCC-CA--ACCA--T---ATTC-T-A-T--TTAGA-
clone 
CONS.A ------------------- --------------------------------------------------- 5 (+) 
CONS.B ------------------------------------------ G-------G----------T-------------- 9 (+) 
2P13 ---------- ----------------------------------------C------ -------- 1 (+) 
2P14 -------------------G-------------------------------------------------------- 1 (+) 
2P16 -------------------------------------C-------------------------------------- 1 (+) 
2P17 ------------------------------------------------G------------------ --------------------------- 1 
2B03 -----------------------------------------------------------------------C---- 1 (+) 
2B04 ---------------------------A------------------------------G---------------G- 1 (+) 
2B06 ------------------C--------------------------------------------------------- 1 (+) 
2B18 -------------------------------------------------T-------------------------- 1 (+) 
2P03 ----------------------------------------- GG------- G---------- T----------- A-- 1 (+) 
2P04 ------------------------------------------G-------G----------T--------C----- 1 (+) 
2P05 ------------------------------------------G-------G----------T----------C--- 1 (+) 
2P06 --------------------------------------- GA-G-------G--------C-T-------------- 1 (+) 
2P09 ------------------------------------------ G--G----G----------T---- -------------- 1 
2B07 ------------------------------------------ G-T-----G----------T -------- 1 (+) 
2B12 ------C--------- -----------------G-------G----------T---G---------- 1 (+) 
2B13 ---A---------- G--------------------------- G------- G---------- T-------------- 1 (+) 
2B20 ------------------------------T-----------G-------G----------T-------------- 1 (+) 
2P01 A---------------T----------------------------------------------------------- 1 (-) 
2P02 -------------------------------------G----G-------G----------T-C------------ 1 (-) 
2P10 -A--------------- -------------------G-------G--- T-------------- 1 (-) 
2P11 -C--------------- C----------------- C------ G------- GG--------- T------------- 1 (-) 
2B01 -A----------------------A-----------------G-------G----------T-------------- .1 (-) 
2B08 ---------------C-------C------------------G-------G----------T-------------- 1 (-) 
2B16 --------------------- C--------------------------------------------- C-------- 1 (-) 
2B17 --------------------- C-------------- C----- G------- G--------- Cr-------------- 1 (-)
Fig. 3 Nucleotide sequence variation among in vivo-derived HTLV-I tax clones. The whole Tax-ORF 
amplified from a sample DNA was ligated into pCG, and randomly selected plasmid clones were 
sequenced. Nucleotide sequences of 39 tax clones derived from an HTLV-I-infected individuals, I.T.are 
aligned in comparison with the reference ATK135'. Dots indicate sequences identical to the reference. 
Italicized letters indicate nonsynonymous substitutions, and those resulting in the translational terminal 
codon, in particular, are underlined. The dominant sequences in the individual are indicated as consensus 
sequences (CONS.). The number of clones identical to a given nucleotide sequence (FREQ) and the 
positive (+) or negative (-) result for the colorimetric assay (COLOR. ASSAY) in transfected 
pA 18G-BHK-21 cells are shown on the right.
        1 amino acids position 353 AMINO ACID CHANGES 
ATK1 F--G-------LRS--------S-----LG---LV-G-----------L----SF--S------------
CONS.A ---------------------- ------------------ -------- ATK1 
CONS.B ------------------------------------------------V--------------------- L241V. 
2P01 Y-----------* F7Y, R74* 
2P10 ---R ------------------------------------------------------------- G14R. 
2P11 ---R---------P-------------------P---------------A-------------------- G14R, S77P, L167P, T243A. 
2B01 ---R-------------------------E---------------------------------------- G14R, G148E. 
2B08 -----------P----------------P----------------------------------------- L71P, L146P. 
2B16 ---------------------- P---------------------------------- P------------ S113P, S293P. 
2B17 ----------------------P-----------A------------------P---------------- S113P, V171A, S273P. 
2P02 ------------------------------------R-----------------S--------------- G180R, F278S 
Fig. 4 Predicted amino acid changes in non-functional Tax proteins encoded by in vivo-derived mutants. Predicted amino acid 
sequences of non-functional Tax are aligned in comparison with the reference ATK136'. In the alignment, the one-letter code 
is used. Dots indicate identity to the reference sequences, and asterisks indicate in-phase termination codons. The positions of 
amino acid substitutions in each protein are indicated on the right.
Discussion 
 The present study has strongly suggested that a 
significant proportion of the tax gene of HTLV-I provi 
ruses in infected individuals is functionally defective. 
DNA sequencing of the tax clones from an individual 
revealed that the defective clones contained at least 
one nonsynonymous nucleotide substitution from the 
consensus sequences of the individual. The Tax protein 
activates viral transcription through interactions with 
the cellular transcription factor, the cyclic AMP response 
element (CRE)-binding protein (CREB), and its coactivator, 
CREB binding protein (CBP)37'38). Tax is thought to stabilize 
CREB-DNA binding"' and also to serve as a bridging 
molecule to recruit CBP to the viral promoter401. Previous 
in vitro mutagenesis studies have revealed that nonfunctional 
missense mutants involve residues located throughout 
the linear tax sequence"". This strongly suggests that 
subtle alterations in the protein structure have dramatic 
effects on Tax function by affecting some aspects of the 
complex interaction with cellular proteins. The random 
localization of amino acid substitution in in vivo-derived 
nonfunctional tax clones identified in the present study 
is consistent with this notion. Interestingly, duplicated T-C 
conversions resulting in a proline residue were frequently 
found in these missense tax mutants. Proline is one of 
aliphatic amino acids but is distinct from other members 
because of its aliphatic side chain bonded to both the 
nitrogen and the a -carbon atom"'. The resulting cyclic 
structure markedly influences protein architecture. It is 
conceivable that duplicated proline substitutions dra-
matically change the secondary or tertiary structure of 
Tax and affects its interaction with cellular proteins. 
 Because Tax is thought to be indispensable for HTLV-I 
replication in infected cells, the provirus encoding non-
functional Tax should be transcriptionally silent and
should therefore no longer be infectious. Accordingly, 
it is likely that such a defective virus is generated in 
individuals after the event of infection. Reverse tran-
scription, an error-prone process, presumably leads to 
the introduction of inactivating mutations during viral 
replication. Recently, Saito et al."' have demonstrated 
the sequence variation of the LTR region of HTLV-I 
proviruses in an infected individual at a similarly high 
level as the tax gene. Our preliminary study has also 
revealed an equivalent or higher level of variation in 
the env region (A.M., unpublished results). If a mutation 
occurs at an equivalent frequency throughout the 
whole HTLV-I genome, a significant number of mu-
tants involving regions other than the tax region would 
also be replication defective. Moreover, the presence of 
proviruses lacking a long gag-pol region in ATL cells 
has been well documented44.45,46>. With the frequency of 
proviruses with nonfunctional tax ranging from 16-35%, 
the majority of HTLV-I proviruses in infected individuals 
might be defective. In the case of another human retrovirus, 
HIV, a recent report has revealed that a significant 
population of the tat gene encoding a HIV transactivator 
in infected individuals is defective and has estimated 
that only about 0.005% of integrated HIV proviruses 
could produce the infectious virus, but that such a 
minute fraction is sufficient to maintain a persistent 
infection 41). Presumably, this is also the case in HTLV-I, 
and the parental or conserved strain (the consensus strain 
in an individual) maintains persistency in vivo. In contrast 
to the intrastrain variability, little divergence in nucleotide 
sequence has been identified among HTLV-I isolates, 
even among those derived from different geographical 
regions in the world 1,41). This discrepancy could be well 
explained if the replication-competent strain with a 
highly conserved sequence alone is inheritable. 
 In comparison with healthy carriers, HAM / TSP
patients revealed a smaller proportion of the defective 
tax clone. Although mechanisms generating the HTLV-I 
quasispecies in vivo remain to be elucidated, it is possible 
that some factors with roles in determining the outcome 
of HTLV-I infection might affect the tax quasispecies. 
One of the candidates for such a factor is the level of 
CTL responses in HTLV-I-infected individuals, since Tax 
is an immunodominant protein in those responses","'. 
While CTL is sometimes detectable against other viral 
proteins such as Gag, Pol, and Env, in most cases Tax 
is the only protein recognized by CTL in the PBMC. 
Multiple CTL peptide epitopes have been identified in 
the linear sequence of Tax. An anti-Tax CTL response 
is likely to be one of the major limiting factors for 
HTLV-I replication in vivo and may select escape Tax 
variants with altered amino acid sequences in target 
peptides of CTLs. It is conceivable that an accumulation of 
nonfunctional tax in infected individuals is a consequence 
of such a positive selection. Indeed, according to a recent 
report by Niewiesk et al. 12', the ratio of nonsynonymous 
versus synonymous nucleotide substitutions in variant 
tax sequences is consistently higher in healthy carriers 
than in HAM/TSP patients. Low CTL responders would 
develop a high viral load with less sequence diversity, 
and the resulting chronic T cell activation causes tissue 
damages such as that seen in HAM /TSP patients49'. 
More extensive sequence comparison together with 
immunological analyses are under in progress in our 
laboratory to evaluate the proposed role for the CTL 
response in the outcome of HTLV-I infection and the 
quasispecies. 
 A number of literature reports have described the 
involvement of defective or variant viruses in the 
chronic infection or pathogenesis of the wild-type vi-
ruses through a modulation of their replication and 
immune responses in vivo. The defective genome of some 
RNA viruses interfering with the replication of wild-type 
viruses are well known as defective interfering (DI) 
particles50'. The involvement of defective C-type retroviruses 
in the immunosuppression of infected animals has also 
been well documented5'•52.53' More recent studies have 
revealed that naturally occurring variant sequences of 
hepatitis B virus or HIV efficiently interfere with the 
recognition of wild-type peptides by CTL, resulting in the 
protection of infected cells from CTL attacks54•55' It would 
be worthwhile to elucidate the role of the accumulated 
defective HTLV-I in the latency and pathogenicity of 
the virus. Tax is a multifunctional protein and considered 
to play an important role in activating various cellular 
genes involving the cell growth and inflammatory cell 
responses. This process involves activation of the particular 
transcriptional factors including NF-kB19,20,Z1) and serum 
response factor (SRF) 25', which are distinct from the
CREB/CBP pathway used for the HTLV-I LTR activation. 
It would be of particular interest to examine whether 
the in vivo-derived Tax variants lacking the potential 
to activate the viral promoter preserve the function in 
the transcriptional activation of cellular genes via the 
NF-kB or SRF pathways.
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